Sunifiram and Unifiram both come up in the same conversations; they overlap on Glutamate and Acetylcholine. Sunifiram: Sunifiram (DM-235) is a synthetic nootropic structurally related to piracetam but dramatically more potent, active at very low doses. Unifiram: Unifiram (DM232) is an exceptionally potent synthetic nootropic developed by Italian medicinal chemists as a next-generation cognition enhancer.
Sunifiram (DM-235) is a synthetic nootropic structurally related to piracetam but dramatically more potent, active at very low doses. It enhances learning and memory by acting on the glycine site of the NMDA receptor and strengthening AMPA-mediated signaling through the CaMKII and PKC pathways, the molecular basis of long-term potentiation. In animal studies it improves cognition and reverses drug-induced amnesia at doses roughly a thousandfold lower than classic racetams, making it one of the most potent research nootropics of its kind.
Unifiram (DM232) is an exceptionally potent synthetic nootropic developed by Italian medicinal chemists as a next-generation cognition enhancer. Structurally related to the ampakines and to piracetam, it was reported in preclinical studies to be roughly four orders of magnitude more potent than piracetam at reversing memory impairment. This remarkable potency, paired with an ampakine-like boost to learning circuitry, has made unifiram a headline compound in the research-chemical nootropic scene.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
facilitates
enhances (ampakine-like)
stimulates downstream
activates
increases
supports
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.
easiest to source: Sunifiram is currently listed by more trusted vendors (2), so it's the simpler one to get hold of. for effects and safety, read each full entry; this is educational, not medical advice.